Skip to Main Content Menu Search Site

Technologies

We aim to have near-term impact in the world by developing groundbreaking bioinspired technologies, ranging from novel devices and materials to high-value therapeutics and diagnostics, that are translated into commercial products and solutions. If you are interested in any of these technologies, please contact us.

Opportunity Type:

floating garbage on the sea , dirty dump in ocean
Plastivores: Plastic-Degrading Super-Microbes and Enzymes

The Plastic Degradation project identifies microbes from natural sources that have a low-level ability to degrade multiple types of plastic. In the laboratory, with the help of synthetic biology, those microbes then are evolved into much more effective plastic-eating microbes that, in the future, could be globally deployed to decompose plastic waste.

Wearable Technology for True Movement Quantification
Wearable Technology for True Movement Quantification

WurQ combines wearable sensors, with deep learning and signal processing algorithms, to assess the amount, quality, and intensity of functional movements and strength training activities. This quantitative data enables feedback, guidance, and gamification at scale to improve users fitness routines and health.

Human Ovarian Organoids to Improve Women’s Health
Human Ovarian Organoids to Improve Women’s Health

Gameto is using the Wyss Institute’s fully human ovarian organoid technology to solve the global problem of rising infertility by making IVF safer, cheaper, and more accessible.

Manufacturing Mini Surgical Robots
Manufacturing Mini Surgical Robots

Project 1985 is commercializing the Wyss Institute’s Pop-Up MEMS technology to quickly and cheaply develop tiny robotic tools for minimally invasive surgery.

CogniXense for Rare Disease Drug Discovery
CogniXense for Rare Disease Drug Discovery

Unravel Biosciences has licensed a Wyss drug discovery platform technology to identify and create drugs to treat complex central nervous system disorders, starting with Rett syndrome.

eRNA: Controlled Enzymatic RNA Oligonucleotide Synthesis
eRNA: Controlled Enzymatic RNA Oligonucleotide Synthesis

Synthetic RNA oligonucleotides designed as specific successions of the four nucleobases A, U, G, and C that mimic naturally occurring RNA species are the key components of diverse RNA-based therapies. These include RNA therapeutics that can partially or completely turn off the expression of disease-causing genes (antisense and interfering RNAs), help replace or supplement dysfunctional...

View More
Close menu